/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

PDS BIOTECHNOLOGY CORP Share Price Today: Live Updates & Key Insights

PDS BIOTECHNOLOGY CORP share price today is $0.6416, up -8.65%. The stock opened at $0.6311 against the previous close of $0.6251, with an intraday high of $0.6311 and low of $0.5311.

PDS BIOTECHNOLOGY CORP Share Price Chart

style
pb-0

PDS BIOTECHNOLOGY CORP

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

PDS BIOTECHNOLOGY CORP Share Price Performance

$0.6416 -0.0865(-8.65%) PDSB at 23 Mar 2026 02:42 PM Biotechnology
Lowest Today 0.5311
Highest Today 0.6311
Today’s Open 0.6311
Prev. Close 0.6251
52 Week High 1.92
52 Week Low 0.52
Day’s Range: Low 0.5311 High 0.6311
52-Week Range: Low 0.52 High 1.92
1 day return -
1 Week return -11.59
1 month return -12.03
3 month return -36.87
6 month return -47.97
1 year return -58.83
3 year return -90.39
5 year return -89.41
10 year return -

PDS BIOTECHNOLOGY CORP Institutional Holdings

Armistice Capital, LLC 5.79

Vanguard Group Inc 3.98

Vanguard Total Stock Mkt Idx Inv 2.03

Vanguard Institutional Extnd Mkt Idx Tr 1.20

Geode Capital Management, LLC 1.06

BlackRock Inc 1.06

Fidelity Extended Market Index 0.57

Blair William & Co 0.51

UBS Group AG 0.41

Commonwealth Equity Services Inc 0.40

Squarepoint Ops LLC 0.39

Integrys Wealth Advisors LLC 0.37

Renaissance Technologies Corp 0.36

State Street Corp 0.27

iShares Micro-Cap ETF 0.24

Northern Trust Corp 0.23

NT Ext Equity Mkt Idx Fd - L 0.21

Blackrock Extended Mkt Fund CF 0.18

Extended Equity Market Fund K 0.16

Amussen, Hunsaker & Associates Incorporated 0.15

Northern Trust Extended Eq Market Idx 0.15

Fidelity Total Market Index 0.14

Acadian Asset Management LLC 0.13

Tempus Wealth Planning, LLC 0.13

Fidelity Series Total Market Index 0.13

Spartan Extended Market Index Pool F 0.12

Watts Gwilliam and Company, LLC 0.11

Vanguard Balanced Index Inv 0.10

NT Ext Equity Mkt Idx Fd - NL 0.08

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.08

Susquehanna International Group, LLP 0.08

Spartan Total Market Index Pool G 0.08

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

ACT Capital Management, LLC 0.06

Bank of New York Mellon Corp 0.06

Rockefeller Capital Management L.P. 0.05

Fidelity Nasdaq Composite Index 0.03

Blackrock US Eq Mkt Fund CF 0.03

Vanguard U.S. Eq Idx £ Acc 0.03

PDS BIOTECHNOLOGY CORP Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

PDS BIOTECHNOLOGY CORP Fundamentals

Market Cap 31.25 M

PB Ratio 3.6184

PE Ratio 0.0

Enterprise Value 25.97 M

Total Assets 45.36 M

Volume 854748

PDS BIOTECHNOLOGY CORP Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-51181665 -51.2M, FY22:-40854855 -40.9M, FY21:-16918477 -16.9M, FY20:-14847380 -14.8M, FY19:-6998606 -7.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-15129 -0.0M, Q1/2025:-15129 -0.0M, Q3/2024:null 0.0M, Q2/2024:-15128 -0.0M

Quarterly Net worth Q3/2025:-9009411 -9.0M, Q2/2025:-9434208 -9.4M, Q1/2025:-8488967 -8.5M, Q3/2024:-10726658 -10.7M, Q2/2024:-8327897 -8.3M

About PDS BIOTECHNOLOGY CORP & investment objective

Company Information PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company's lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. Further, the company provides PDS0202, a novel investigational influenza vaccine that protects against the strains predicted to be prevalent in an upcoming flu season. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.

Organisation Biotechnology

Employees 24

Industry Biotechnology

CEO Dr. Frank K. Bedu-Addo Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

PDS BIOTECHNOLOGY CORP FAQs

What is the share price of PDS BIOTECHNOLOGY CORP today?

The current share price of PDS BIOTECHNOLOGY CORP is $0.6416.

Can I buy PDS BIOTECHNOLOGY CORP shares in India?

Yes, Indian investors can buy PDS BIOTECHNOLOGY CORP shares by opening an international trading and demat account with Motilal Oswal.

How to buy PDS BIOTECHNOLOGY CORP shares in India?

You can easily invest in PDS BIOTECHNOLOGY CORP shares from India by:

Can I buy fractional shares of PDS BIOTECHNOLOGY CORP?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of PDS BIOTECHNOLOGY CORP?

PDS BIOTECHNOLOGY CORP has a market cap of $31.25 M.

In which sector does PDS BIOTECHNOLOGY CORP belong?

PDS BIOTECHNOLOGY CORP operates in the Biotechnology sector.

What documents are required to invest in PDS BIOTECHNOLOGY CORP stocks?

To invest, you typically need:

What is the PE and PB ratio of PDS BIOTECHNOLOGY CORP?

The PE ratio of PDS BIOTECHNOLOGY CORP is N/A and the PB ratio is 3.62.